The American psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia

American Journal of Psychiatry

Volumn 173, Issue 5, 2016, Pages 543-546

  Reus, Victor I ^a   Fochtmann, Laura J ^a   Eyler, A Evan ^a   Hilty, Donald M ^a   Horvitz Lennon, Marcela ^a   Jibson, Michael D ^a   Lopez, Oscar L ^a   Mahoney, Jane ^a   Pasic, Jagoda ^a   Tan, Zaldy S ^a   Wills, Cheryl D ^a   Rhoads, Richard ^a   Yager, Joel ^a  

^a APA Practice Guideline Writing Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CAREGIVER BURDEN; CLINICAL FEATURE; DEMENTIA; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RESTLESSNESS; TREATMENT PLANNING; COMPLICATION; CONSENSUS DEVELOPMENT; PATHOPHYSIOLOGY; PSYCHOLOGY; UNITED STATES;

ANTIPSYCHOTIC AGENTS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DEMENTIA; HUMANS; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; UNITED STATES;

EID: 84965160749     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.173501     Document Type: Article

References (13)

1. Agency for Healthcare Research and Quality: Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(14)-EHC063-EF. Rockville, MD, Agency for Healthcare Research and Quality. January 2014. Available at: Http://www.effectivehealthcare. ahrq.gov/search-for-guides-reviews-and-reports/?pageaction5 displayproduct&productid5318
2. Andrews JC, Schünemann HJ, Oxman AD, et al: GRADE guidelines: 15. Going from evidence to recommendation: Determinants of a recommendation's direction and strength. J Clin Epidemiol 2013; 66(7):726-735
3. Balshem H, Helfand M, Schünemann HJ, et al: GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64(4):401-406
4. Brito JP,DomecqJP,MuradMH,et al:TheEndocrine Society guidelines: When the confidence cart goes before the evidence horse. J Clin Endocrinol Metab 2013; 98(8):3246-3252
5. Corbett A, Burns A, Ballard C: Don't use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ 2014; 349:g6420
6. Council of Medical Specialty Societies (CMSS): Principles for the Development of Specialty Society Clinical Guidelines. Chicago, IL, Council of Medical Specialty Societies, 2012
7. Djulbegovic B, Trikalinos TA, Roback J, et al: Impact of quality of evidence on the strength of recommendations: An empirical study. BMC Health Serv Res 2009; 9:120
8. Guyatt G, Eikelboom JW, Akl EA, et al: A guide to GRADE guidelines for the readers of JTH. J Thromb Haemost 2013; 11(8):1603-1608
9. Guyatt G, Gutterman D, Baumann MH, et al: Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of ChestPhysicians task force.Chest 2006; 129(1):174-181
10. Hazlehurst JM, Armstrong MJ, Sherlock M, et al: A comparative quality assessment of evidence-based clinical guidelines in endocrinology. Clin Endocrinol (Oxf ) 2013; 78(2):183-190
11. Kales HC, Gitlin LN, Lyketsos CG: Assessment and management of behavioral and psychological symptoms of dementia. BMJ 2015; 350: H369
12. Shiffman RN, Dixon J, Brandt C, et al: The GuideLine Implementability Appraisal (GLIA): Development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak 2005; 5:23
13. Yager J, Kunkle R, Fochtmann LJ, et al: Who's your expert?Use of an expert opinion survey to inform development of American Psychiatric Association practice guidelines. Acad Psychiatry 2014; 38(3): 376-382